share_log

Clarity Pharmaceuticals Ltd: First 2 participants dosed with Cu-64 SAR-bisPSMA in Co-PSMA

ASX ·  Nov 26 06:56
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more